|
Volumn 28, Issue 7, 2001, Pages 902-908
|
Current status of adjuvant endocrine therapy for hormone responsive breast cancer
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIESTROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
AROMATASE INHIBITOR;
ENZYME INHIBITOR;
GONADORELIN;
TAMOXIFEN;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG POTENTIATION;
FEMALE;
HUMAN;
MENOPAUSE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
ENZYME INHIBITORS;
ESTROGEN ANTAGONISTS;
FEMALE;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
MENOPAUSE;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
TAMOXIFEN;
|
EID: 0035403487
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (4)
|
References (14)
|